Pages that link to "Q71368928"

The following pages link to The effect of mannitol on the oral bioavailability of cimetidine (Q71368928):

Displaying 20 items.

• The biopharmaceutics classification system (BCS): class III drugs - better candidates for BA/BE waiver? (Q33808549) (← links)
• A systematic and mechanistic evaluation of aspartic acid as filler for directly compressed tablets containing trimethoprim and trimethoprim aspartate (Q34498862) (← links)
• Formulation strategies for absorption windows (Q36039930) (← links)
• Effects of commonly used excipients on the expression of CYP3A4 in colon and liver cells (Q37031501) (← links)
• Impact of osmotically active excipients on bioavailability and bioequivalence of BCS class III drugs (Q37207781) (← links)
• Multiple peaking phenomena in pharmacokinetic disposition. (Q37756115) (← links)
• Impact of excipient interactions on drug bioavailability from solid dosage forms (Q38011598) (← links)
• Influence of polyethylene glycol 400 on the gastrointestinal absorption of ranitidine (Q44196291) (← links)
• Concentration-dependent effects of polyethylene glycol 400 on gastrointestinal transit and drug absorption (Q44729481) (← links)
• Lack of bioequivalence between two aciclovir tablets in healthy subjects (Q46849378) (← links)
• Effect of Sorbitol on the Pharmacokinetic Profile of Lamivudine Oral Solution in Adults: An Open-Label, Randomized Study (Q49908214) (← links)
• A Modern View of Excipient Effects on Bioequivalence: Case Study of Sorbitol (Q58869647) (← links)
• Sex-Dependence in the Effect of Pharmaceutical Excipients: Polyoxyethylated Solubilising Excipients Increase Oral Drug Bioavailability in Male but not Female Rats. (Q64968997) (← links)
• Drug-excipient interactions and their affect on absorption (Q73120411) (← links)
• Equivalence-by-design: targeting in vivo drug delivery profile (Q79713761) (← links)
• Feasibility of biowaiver extension to biopharmaceutics classification system class III drug products: cimetidine (Q83053405) (← links)
• Impact of formulation excipients on human intestinal transit (Q83875824) (← links)
• The Developability Classification System: Application of Biopharmaceutics Concepts to Formulation Development (Q84990410) (← links)
• Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients? (Q92866132) (← links)
• The provisional no-effect threshold of sugar alcohols on oral drug absorption estimated by physiologically based biopharmaceutics model (Q96017548) (← links)